View Financial HealthAccentis 配当と自社株買い配当金 基準チェック /06Accentis現在配当金を支払っていません。主要情報0%配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向0%最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesBuy Or Sell Opportunity • May 05Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.3% to €0.025. The fair value is estimated to be €0.033, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.0% over the last 3 years. Earnings per share has grown by 6.9%.Reported Earnings • Apr 20Full year 2024 earnings released: EPS: €0.001 (vs €0.002 in FY 2023)Full year 2024 results: EPS: €0.001 (down from €0.002 in FY 2023). Revenue: €6.38m (down 8.6% from FY 2023). Net income: €779.0k (down 70% from FY 2023). Profit margin: 12% (down from 37% in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 75 percentage points per year, which is a significant difference in performance.New Risk • Mar 14New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 22% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (6.9% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (€39.8m market cap, or US$43.2m).Buy Or Sell Opportunity • Dec 17Now 21% undervaluedOver the last 90 days, the stock has risen 3.6% to €0.029. The fair value is estimated to be €0.037, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 48% over the last 3 years. Earnings per share has declined by 70%.分析記事 • Dec 14Estimating The Intrinsic Value Of Accentis N.V. (EBR:ACCB)Key Insights The projected fair value for Accentis is €0.037 based on 2 Stage Free Cash Flow to Equity With €0.029...Buy Or Sell Opportunity • Nov 22Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 3.6% to €0.027. The fair value is estimated to be €0.035, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 48% over the last 3 years. Earnings per share has declined by 70%.New Risk • Nov 07New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Belgian stocks, typically moving 6.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (6.4% average weekly change). Earnings have declined by 22% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (€34.1m market cap, or US$36.7m).Buy Or Sell Opportunity • Nov 06Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 10.0% to €0.027. The fair value is estimated to be €0.036, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 48% over the last 3 years. Earnings per share has declined by 70%.Buy Or Sell Opportunity • Oct 17Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.5% to €0.027. The fair value is estimated to be €0.036, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 48% over the last 3 years. Earnings per share has declined by 70%.分析記事 • Sep 07Accentis' (EBR:ACCB) Earnings Offer More Than Meets The EyeThe market seemed underwhelmed by last week's earnings announcement from Accentis N.V. ( EBR:ACCB ) despite the healthy...New Risk • Aug 28New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 26% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 22% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.0% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (€34.7m market cap, or US$38.6m).New Risk • Aug 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Belgian stocks, typically moving 4.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 13% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (4.7% average weekly change). Market cap is less than US$100m (€37.3m market cap, or US$40.9m).Board Change • Jun 11Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Axelle Vanthournout was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 29Full year 2023 earnings released: EPS: €0.002 (vs €0 in FY 2022)Full year 2023 results: EPS: €0.002 (up from €0 in FY 2022). Revenue: €7.02m (down 7.5% from FY 2022). Net income: €2.60m (up €2.26m from FY 2022). Profit margin: 37% (up from 4.5% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.New Risk • Aug 30New major risk - Revenue and earnings growthEarnings have declined by 4.1% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Dividend per share is over 14x earnings per share. Cash payout ratio: 377% Earnings have declined by 4.1% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.1% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (11% net profit margin). Market cap is less than US$100m (€34.9m market cap, or US$38.1m).New Risk • Aug 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Belgian stocks, typically moving 4.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Dividend per share is over 33x earnings per share. Cash payout ratio: 418% Minor Risks Share price has been volatile over the past 3 months (4.8% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.5% net profit margin). Market cap is less than US$100m (€36.6m market cap, or US$40.1m).Reported Earnings • Feb 22Full year 2022 earnings released: EPS: €0 (vs €0.013 in FY 2021)Full year 2022 results: EPS: €0 (down from €0.013 in FY 2021). Revenue: €7.59m (down 64% from FY 2021). Net income: €339.0k (down 98% from FY 2021). Profit margin: 4.5% (down from 81% in FY 2021). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings.分析記事 • Aug 31Estimating The Intrinsic Value Of Accentis N.V. (EBR:ACCB)How far off is Accentis N.V. ( EBR:ACCB ) from its intrinsic value? Using the most recent financial data, we'll take a...Board Change • May 19Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Mieke De Clercq was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 24Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: €0.013 (up from €0.005 in FY 2020). Revenue: €32.9m (up 64% from FY 2020). Net income: €17.0m (up 193% from FY 2020). Profit margin: 52% (up from 29% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 18% per year.分析記事 • Apr 08We Think Accentis (EBR:ACCB) Can Stay On Top Of Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...分析記事 • Mar 13Is Accentis N.V.'s (EBR:ACCB) Recent Stock Performance Influenced By Its Fundamentals In Any Way?Accentis' (EBR:ACCB) stock is up by a considerable 7.1% over the past month. We wonder if and what role the company's...分析記事 • Dec 27Accentis (EBR:ACCB) Has A Somewhat Strained Balance SheetSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...分析記事 • Dec 06A Look At The Fair Value Of Accentis N.V. (EBR:ACCB)How far off is Accentis N.V. ( EBR:ACCB ) from its intrinsic value? Using the most recent financial data, we'll take a...分析記事 • Nov 17Is Accentis N.V.'s (EBR:ACCB) Recent Performance Tethered To Its Attractive Financial Prospects?Accentis' (EBR:ACCB) stock is up by 3.1% over the past month. Since the market usually pay for a company’s long-term...決済の安定と成長配当データの取得安定した配当: ACCBの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: ACCBの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Accentis 配当利回り対市場ACCB 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (ACCB)0%市場下位25% (BE)2.2%市場トップ25% (BE)7.0%業界平均 (Real Estate)4.3%アナリスト予想 (ACCB) (最長3年)n/a注目すべき配当: ACCBは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: ACCBは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: ACCB Belgian市場において目立った配当金を支払っていません。株主配当金キャッシュフローカバレッジ: ACCBが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YBE 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/21 06:02終値2026/08/21 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Accentis N.V. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Buy Or Sell Opportunity • May 05Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.3% to €0.025. The fair value is estimated to be €0.033, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.0% over the last 3 years. Earnings per share has grown by 6.9%.
Reported Earnings • Apr 20Full year 2024 earnings released: EPS: €0.001 (vs €0.002 in FY 2023)Full year 2024 results: EPS: €0.001 (down from €0.002 in FY 2023). Revenue: €6.38m (down 8.6% from FY 2023). Net income: €779.0k (down 70% from FY 2023). Profit margin: 12% (down from 37% in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 75 percentage points per year, which is a significant difference in performance.
New Risk • Mar 14New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 22% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (6.9% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (€39.8m market cap, or US$43.2m).
Buy Or Sell Opportunity • Dec 17Now 21% undervaluedOver the last 90 days, the stock has risen 3.6% to €0.029. The fair value is estimated to be €0.037, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 48% over the last 3 years. Earnings per share has declined by 70%.
分析記事 • Dec 14Estimating The Intrinsic Value Of Accentis N.V. (EBR:ACCB)Key Insights The projected fair value for Accentis is €0.037 based on 2 Stage Free Cash Flow to Equity With €0.029...
Buy Or Sell Opportunity • Nov 22Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 3.6% to €0.027. The fair value is estimated to be €0.035, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 48% over the last 3 years. Earnings per share has declined by 70%.
New Risk • Nov 07New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Belgian stocks, typically moving 6.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (6.4% average weekly change). Earnings have declined by 22% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (€34.1m market cap, or US$36.7m).
Buy Or Sell Opportunity • Nov 06Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 10.0% to €0.027. The fair value is estimated to be €0.036, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 48% over the last 3 years. Earnings per share has declined by 70%.
Buy Or Sell Opportunity • Oct 17Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.5% to €0.027. The fair value is estimated to be €0.036, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 48% over the last 3 years. Earnings per share has declined by 70%.
分析記事 • Sep 07Accentis' (EBR:ACCB) Earnings Offer More Than Meets The EyeThe market seemed underwhelmed by last week's earnings announcement from Accentis N.V. ( EBR:ACCB ) despite the healthy...
New Risk • Aug 28New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 26% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 22% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.0% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (€34.7m market cap, or US$38.6m).
New Risk • Aug 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Belgian stocks, typically moving 4.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 13% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (4.7% average weekly change). Market cap is less than US$100m (€37.3m market cap, or US$40.9m).
Board Change • Jun 11Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Axelle Vanthournout was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 29Full year 2023 earnings released: EPS: €0.002 (vs €0 in FY 2022)Full year 2023 results: EPS: €0.002 (up from €0 in FY 2022). Revenue: €7.02m (down 7.5% from FY 2022). Net income: €2.60m (up €2.26m from FY 2022). Profit margin: 37% (up from 4.5% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.
New Risk • Aug 30New major risk - Revenue and earnings growthEarnings have declined by 4.1% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Dividend per share is over 14x earnings per share. Cash payout ratio: 377% Earnings have declined by 4.1% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.1% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (11% net profit margin). Market cap is less than US$100m (€34.9m market cap, or US$38.1m).
New Risk • Aug 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Belgian stocks, typically moving 4.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Dividend per share is over 33x earnings per share. Cash payout ratio: 418% Minor Risks Share price has been volatile over the past 3 months (4.8% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.5% net profit margin). Market cap is less than US$100m (€36.6m market cap, or US$40.1m).
Reported Earnings • Feb 22Full year 2022 earnings released: EPS: €0 (vs €0.013 in FY 2021)Full year 2022 results: EPS: €0 (down from €0.013 in FY 2021). Revenue: €7.59m (down 64% from FY 2021). Net income: €339.0k (down 98% from FY 2021). Profit margin: 4.5% (down from 81% in FY 2021). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings.
分析記事 • Aug 31Estimating The Intrinsic Value Of Accentis N.V. (EBR:ACCB)How far off is Accentis N.V. ( EBR:ACCB ) from its intrinsic value? Using the most recent financial data, we'll take a...
Board Change • May 19Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Mieke De Clercq was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 24Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: €0.013 (up from €0.005 in FY 2020). Revenue: €32.9m (up 64% from FY 2020). Net income: €17.0m (up 193% from FY 2020). Profit margin: 52% (up from 29% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 18% per year.
分析記事 • Apr 08We Think Accentis (EBR:ACCB) Can Stay On Top Of Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
分析記事 • Mar 13Is Accentis N.V.'s (EBR:ACCB) Recent Stock Performance Influenced By Its Fundamentals In Any Way?Accentis' (EBR:ACCB) stock is up by a considerable 7.1% over the past month. We wonder if and what role the company's...
分析記事 • Dec 27Accentis (EBR:ACCB) Has A Somewhat Strained Balance SheetSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
分析記事 • Dec 06A Look At The Fair Value Of Accentis N.V. (EBR:ACCB)How far off is Accentis N.V. ( EBR:ACCB ) from its intrinsic value? Using the most recent financial data, we'll take a...
分析記事 • Nov 17Is Accentis N.V.'s (EBR:ACCB) Recent Performance Tethered To Its Attractive Financial Prospects?Accentis' (EBR:ACCB) stock is up by 3.1% over the past month. Since the market usually pay for a company’s long-term...